An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin
Clinical trial NCT02433678 · COMPLETED
Trial details
- NCT number
- NCT02433678
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-03-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.